Skip to main content
GutCited

Pancreatic Enzymes (Pancrelipase) pour Bloating and Intestinal Gas

A

Standard of care for exocrine pancreatic insufficiency. Pancreatic enzyme replacement therapy (25,000-40,000 lipase units/meal) normalizes fat absorption and helps resolve steatorrhea. FDA-approved medications (Creon, Zenpep).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpancreatic\u002Denzymes\u0026condition\u003Dbloating\u002Dand\u002Dgas'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

Standard of care for exocrine pancreatic insufficiency. Pancreatic enzyme replacement therapy (25,000-40,000 lipase units/meal) normalizes fat absorption and helps resolve steatorrhea. FDA-approved medications (Creon, Zenpep).

Key Study Findings

Randomized Controlled Trial 26 weeks Open-label
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control …
Dose: None vs: Usual nutrition care Outcome: Quality of life (EORTC-QLQ C30 summary score) Effet: None None

Population: Adults with pancreatic cancer (borderline/locally advanced/metastatic)

Case Reports n=1 Open-label
Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review.
Dose: 20 mg once daily vs: None Outcome: Drug-induced pancreatitis Effet: None None

Population: 28-year-old woman with severe depression

Review
Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer.
Dose: Pancreatic enzyme replacement therapy (PERT) vs: None Outcome: EPI symptom management in pancreatic cancer Effet: None None

Population: Patients with pancreatic cancer and EPI

Case Reports
An Infected Intrahepatic Pancreatic Pseudocyst and Calcified Pancreas: A Rare Complication of Chronic Pancreatitis.
Dose: None vs: None Outcome: pain reduction Effet: None None

Population: None

Review
AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert …
Dose: PERT (pancreatic enzyme replacement) vs: None Outcome: EPI diagnosis and treatment guidelines Effet: None None

Population: Patients with exocrine pancreatic insufficiency

Other n=35 26.0 weeks
Isolated Amylase Deficiency in Children and Its Clinical Implication.
Dose: None vs: None Outcome: Diarrhea outcomes Effet: None None

Population: children

Key Statistics

12

Études

800

Participants

Positive

A

Note

Referenced Papers

Pharmacy (Basel, Switzerland) 2024 2 citations
Journal of pediatric … 2019 14 citations
The Medical journal … 2017 59 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
25,000-40,000 lipase units per meal
epiadults:
25,000-50,000 lipase units with meals, 10,000-25,000 with snacks
epipediatric:
500-2,500 lipase units/kg/meal (max 10,000 units/kg/day)

Limite supérieure : 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None 26 weeks Mixed --
20 mg once daily -- Negative 1
Pancreatic enzyme replacement therapy (PERT) -- Positive --
None -- Mixed --
PERT (pancreatic enzyme replacement) -- Positive --
None 26.0 weeks Mixed 35
16 g 8.7 weeks Mixed --
None 52.0 weeks Mixed 20

Moment optimal de prise : With meals and snacks; take half the dose at the beginning and half during the meal

Safety & Side Effects

Effets indésirables signalés

  • Abdominal pain and cramping
  • Nausea
  • Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients)
  • Hyperuricemia (high doses of protease can increase uric acid)

Interactions connues

  • Calcium carbonate and magnesium hydroxide antacids (may reduce enzyme activity)
  • Acarbose and miglitol (pancreatic amylase may counteract alpha-glucosidase inhibitors)
  • Iron supplements (protease may reduce iron absorption)
  • Proton pump inhibitors (may improve enzyme efficacy by reducing acid denaturation)

Apport maximal tolérable : 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Pancreatic Enzymes (Pancrelipase) help with Bloating and Intestinal Gas?
Based on 12 studies with 800 participants, there is strong evidence from multiple clinical trials that Pancreatic Enzymes (Pancrelipase) may support Bloating and Intestinal Gas management. Our evidence grade is A (Strong Evidence).
How much Pancreatic Enzymes (Pancrelipase) should I take for Bloating and Intestinal Gas?
Studies have used various dosages. A commonly studied range is 25,000-40,000 lipase units per meal. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pancreatic Enzymes (Pancrelipase)?
Reported side effects may include Abdominal pain and cramping, Nausea, Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients), Hyperuricemia (high doses of protease can increase uric acid). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pancreatic Enzymes (Pancrelipase) and Bloating and Intestinal Gas?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.